APOPTOTIC AND PROLIFERATIVE ACTIVITY IN OVARIAN BENIGN,BORDERLINE AND MALIGNANT TUMORS

被引:0
|
作者
刘爱军
陈乐真
颜婉嫦
邱玮璇
赵昀
张雅贤
机构
关键词
Ki-67; M30; topoisomerase IIα; ovarian epithelial tumor;
D O I
暂无
中图分类号
R730.2 [肿瘤病理学、病因学];
学科分类号
100214 ;
摘要
Objective.To determine the apoptotic and proliferative activities in various ovarian epithelial tumors.Methods.Formalin-fixed,paraffin-embedded tissues of 86ovarian epithelial tu mors,including 52adenocarcino-mas,23borderline tumors and 11cystadenomas,were retrieved.Apoptoti c(AI )and proliferative(PI )index were estimated using the monoclonal antibodies:M30,Ki-67and Ki-S1in t hese tumors.Quantitative assess-ment of AI and PI was estimated by calc ulating the percentage of positive c ells among no less than 1000tumor cells.Results.Statistically significant differe nce in AI was found between benign and borderline tumors or carcino-mas(P=0.028,0.001,respectively).Significant differences in PI,as a ssessed by both Ki-67and topo IIα,were demonstrated between carcinom as and benign or borderline tumors(both P<0.001).Benign tumors had both low PI and AI;borderline tumors had lower PI but higher AI,while aden ocarcinomas had both high prolifera-tive and high apoptotic rates.Among borderline tumors,serous tumors had significantly lower AI and higher PI than mucinous ones.Conclusions.The results suggest that apoptotic a nd proliferative activities play im portant roles in the pathogene-sis and development of ovarian borderline and malignant tumors.The high apoptotic rate in borderline tumor m ay explain its relatively indolent beh avior while the high proliferative r ate in carcinomas tends to explain its aggres-sive behavior.
引用
收藏
页码:106 / 111
页数:6
相关论文
共 50 条
  • [21] p14 expression differences in ovarian benign, borderline and malignant epithelial tumors
    Vinicius Duarte Cabral
    Marcelle Reesink Cerski
    Ivana Trindade Sa Brito
    Lucia Maria Kliemann
    [J]. Journal of Ovarian Research, 9
  • [22] Clinicopathological study of metallothionein immunohistochemical expression, in benign, borderline and malignant ovarian epithelial tumors
    Zagorianakou, N
    Stefanou, D
    Makrydimas, G
    Zagorianakou, P
    Briasoulis, E
    Karavasilis, V
    Pavlidis, N
    Agnantis, NJ
    [J]. HISTOLOGY AND HISTOPATHOLOGY, 2006, 21 (4-6) : 341 - 347
  • [23] Differential Nuclear Expression of Aurora A Kinase in Benign, Borderline, and Malignant Serous Ovarian Tumors
    Crane, J. E.
    Schultz, D. S.
    Inamdar, K. V.
    Lehman, N. L.
    [J]. LABORATORY INVESTIGATION, 2010, 90 : 238A - 238A
  • [24] Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelial tumors
    Kalir, T
    Wang, BY
    Goldfischer, M
    Reder, E
    Demopoulos, R
    Cohen, CJ
    Burstein, DE
    [J]. MODERN PATHOLOGY, 2002, 15 (01) : 200A - 200A
  • [25] p14 expression differences in ovarian benign, borderline and malignant epithelial tumors
    Cabral, Vinicius Duarte
    Cerski, Marcelle Reesink
    Brito, Ivana Trindade Sa
    Kliemann, Lucia Maria
    [J]. JOURNAL OF OVARIAN RESEARCH, 2016, 9
  • [26] TUMOR-MARKERS IN BENIGN, BORDERLINE AND MALIGNANT OVARIAN-TUMORS OF EPITHELIAL GROWTH
    DIETEL, M
    HOLZEL, F
    SIMON, W
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1983, 105 (02) : A39 - A39
  • [27] Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelial tumors
    Kalir, T
    Wang, BY
    Goldfischer, M
    Reder, E
    Demopoulos, R
    Cohen, CJ
    Burstein, DE
    [J]. LABORATORY INVESTIGATION, 2002, 82 (01) : 200A - 200A
  • [28] Fas and Fas ligand in cyst fluids, serum and tumors of patients with benign and (borderline) malignant ovarian tumors
    Arts, HJG
    De Jong, S
    Hollema, H
    Ten Hoor, KA
    De Vries, EGE
    Van Der Zee, AGJ
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 26 (02) : 379 - 384
  • [29] The proliferative activity of ovarian tumors of low malignant potential differs from that of ovarian carcinoma
    Nakayama, K
    Takebayashi, Y
    Hata, K
    Fujiwaki, R
    Iida, K
    Fukumoto, M
    Miyazaki, K
    [J]. ANTICANCER RESEARCH, 2003, 23 (6C) : 4657 - 4662
  • [30] Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: A clinicopathologic study of 60 cases
    Darai, E
    Scoazec, JY
    WalkerCombrouze, F
    MlikaCabanne, N
    Feldmann, G
    Madelenat, P
    Potet, F
    [J]. HUMAN PATHOLOGY, 1997, 28 (08) : 922 - 928